Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-16T17:09:50.909Z Has data issue: false hasContentIssue false

Local and global gene therapy in the central nervous system

Published online by Cambridge University Press:  04 February 2010

Leslie L. Muldoon
Affiliation:
Department of Cell Biology and Anatomy;
Edward A. Neuwelt
Affiliation:
Department of Neurology, Division of NeurosurgeryDepartment of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, OR 97201. muldoonl@ohsu.edu

Abstract

For focal neurodegenerative diseases or brain tumors, localized delivery of protein or genetic vectors may be sufficient to alleviate symptoms, halt disease progression, or even cure the disease. One may circumvent the limitation imposed by the blood-brain barrier by transplantation of genetically altered cell grafts or focal inoculation of virus or protein. However, permanent gene replacement therapy for diseases affecting the entire brain will require global delivery of genetic vectors. The neurotoxicity of currently available viral vectors and the transient nature of transgene expression in vivo must be overcome before their use in human gene therapy becomes clinically applicable.

Information

Type
Authors' Responses
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable